ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Research Associate at Octant Bio - ApplyBlast

Research Associate

Octant Bio

3 months ago

Emeryville, California, United States

Onsite

Full Time

Junior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Octant is hiring a Research Associate to join its High‑Throughput Screening team, where the role will focus on building, improving, and executing high‑throughput screening workflows, operating automated liquid handling equipment, and analyzing HTS data to support drug discovery programs. The position requires strong technical skills in plate‑based assays, laboratory automation, and quantitative data analysis, and involves close collaboration across functional teams in a fast‑paced, on‑site environment.

Responsibilities

Build and improve high‑throughput screening workflows
Operate automated liquid handling equipment for high‑volume workflows
Analyze and interpret HTS data and troubleshoot assay artifacts
Collaborate with cross‑functional teams to optimize screening strategies
Ensure data quality and generate clean data for drug‑discovery decisions

Skills

Qualifications

BS in BiologyBS in BiochemistryBS in Genetics

About Octant Bio

octant.bio

Headquarters

Emeryville, California, United States

Company Size

51-200 employees

Founded

2017

View Profile

Octant is a biotechnology company that combines next‑generation biology, chemistry, and computation to engineer precision medicines. The company focuses on next‑generation small‑molecule therapeutics that modulate complex cellular mechanisms driving disease, rather than only binding purified protein targets. Octant builds and applies large‑scale biology and chemistry platforms aimed at correcting diseases of protein misfolding and mistrafficking. Their platform‑driven approach expands which cellular processes can be drugged to create new treatment opportunities.